1 results match your criteria: "United Arab Emirates. Electronic address: anu.jacob@thewaltoncentre.nhs.uk.[Affiliation]"
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.
Mult Scler Relat Disord
September 2020
Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom; Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom; Department of Neurology, The Cleveland Clinic Abu Dhabi, United Arab Emirates. Electronic address:
Objective: To assess the effect of anti-CD20 B-cell depletion with rituximab (RTX) on relapse rates in myelin oligodendrocyte glycoprotein antibody-associated disorder (MOGAD).
Methods: Retrospective review of RTX-treated MOGAD patients from 29 centres in 13 countries. The primary outcome measure was change in relapse rate after starting rituximab (Poisson regression model).